新锐医药（股票代码：06108）于2026年5月4日发布截至2026年4月30日的证券变动月报表。公告显示，公司法定股本总数仍为15,000,000,000股普通股，每股面值为0.01港元，总金额为150,000,000港元，与上月保持一致。已发行股份总数为200,616,665股，无库藏股，公司确认符合主要上市规则有关公众持股量的要求。
根据公告，公司本月无新增发行股份、无股份回购及注销。公司现有一项于2013年10月25日采纳的购股权计划，期末持有购股权数量为12,820,000份，与上月相同，报告期内未有新股发行或购回记录。公司同时声明已遵守香港联合交易所相关上市规则及法律规定。本次公告由公司秘书吴日升签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.